Cetera Investment Advisers Has $453,000 Stake in Avantor, Inc. (NYSE:AVTR)

Cetera Investment Advisers decreased its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 47.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,519 shares of the company's stock after selling 19,444 shares during the quarter. Cetera Investment Advisers' holdings in Avantor were worth $453,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AVTR. Brevan Howard Capital Management LP increased its stake in shares of Avantor by 102.6% during the 4th quarter. Brevan Howard Capital Management LP now owns 23,894 shares of the company's stock worth $503,000 after purchasing an additional 12,098 shares during the last quarter. Bayesian Capital Management LP acquired a new position in shares of Avantor during the 4th quarter worth $356,000. Ameriprise Financial Inc. increased its stake in shares of Avantor by 15.9% during the 4th quarter. Ameriprise Financial Inc. now owns 1,645,022 shares of the company's stock worth $34,661,000 after purchasing an additional 225,751 shares during the last quarter. Mercer Global Advisors Inc. ADV acquired a new position in shares of Avantor during the 4th quarter worth $1,552,000. Finally, Freestone Grove Partners LP acquired a new position in shares of Avantor during the 4th quarter worth $6,518,000. Hedge funds and other institutional investors own 95.08% of the company's stock.

Insider Activity at Avantor

In other news, Director Joseph R. Massaro purchased 8,100 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was purchased at an average cost of $12.30 per share, with a total value of $99,630.00. Following the acquisition, the director now directly owns 35,038 shares of the company's stock, valued at approximately $430,967.40. This trade represents a 30.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gregory L. Summe bought 25,000 shares of the company's stock in a transaction on Wednesday, May 7th. The stock was bought at an average cost of $12.00 per share, with a total value of $300,000.00. Following the completion of the purchase, the director now owns 50,000 shares of the company's stock, valued at approximately $600,000. The trade was a 100.00% increase in their position. The disclosure for this purchase can be found here. Insiders bought 83,100 shares of company stock valued at $1,027,630 in the last ninety days. Insiders own 1.20% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. TD Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target on the stock. in a research note on Monday, April 28th. Raymond James reiterated an "outperform" rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Citigroup lowered their target price on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Finally, Robert W. Baird lowered their target price on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $18.88.

Avantor Price Performance

Shares of NYSE:AVTR traded down $0.01 during midday trading on Thursday, reaching $13.03. 7,599,615 shares of the company's stock were exchanged, compared to its average volume of 7,952,506. The company's 50 day simple moving average is $14.22 and its two-hundred day simple moving average is $18.08. The firm has a market capitalization of $8.88 billion, a PE ratio of 12.52, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. Avantor, Inc. has a 12 month low of $11.82 and a 12 month high of $28.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting analysts' consensus estimates of $0.23. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The firm's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same period last year, the firm earned $0.22 EPS. Equities research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.